aluates Reports

$ 0.0

Automative

Global Drug Treatment for Respiratory Disease Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-18T17252

BUY CHAPTERS

Global Drug Treatment for Respiratory Disease Market Research Report 2024

Code: QYRE-Auto-18T17252

Report

May 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Astrazeneca plc

Boehringer Ingelheim

Novartis

Mylan NV

Vertex Pharmaceuticals

F. Hoffman-La Roche

Teva Pharmaceuticals

Cipla Ltd

FibroGen Inc

Liminal Biosciences

PharmAkea Therapeutics

IQVIA

Drug Treatment for Respiratory Disease Market

Respiratory diseases may be caused by infection, by smoking tobacco, or by breathing in secondhand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer.

The global Drug Treatment for Respiratory Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

Nebulization inhalation therapy is an important treatment method for respiratory system-related diseases. Compared with oral administration, intramuscular injection and intravenous administration, aerosol inhalation therapy has the advantages of rapid onset of action, good curative effect, fewer systemic adverse reactions, and does not require the patient's deliberate cooperation because the drug directly acts on the target organ. It has been adopted domestically. Widely used outside.

This report aims to provide a comprehensive presentation of the global market for Drug Treatment for Respiratory Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Treatment for Respiratory Disease.

The Drug Treatment for Respiratory Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Treatment for Respiratory Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Treatment for Respiratory Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Treatment for Respiratory Disease Market Report

Report Metric	Details
Report Name	Drug Treatment for Respiratory Disease Market
Segment by Type	Asthma Chronic Obstructive Pulmonary Disease (COPD) Lung Cancer Other Diseases
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals, Cipla, Fibrogen, Liminal Biosciences, PharmAkea Therapeutics, IQVIA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Treatment for Respiratory Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Treatment for Respiratory Disease Market report?

Ans: The main players in the Drug Treatment for Respiratory Disease Market are GSK, AstraZeneca, Boehringer Ingelheim, Novartis, Mylan, Vertex Pharmaceuticals, F. Hoffman La Roche, Teva Pharmaceuticals, Cipla, Fibrogen, Liminal Biosciences, PharmAkea Therapeutics, IQVIA

What are the Application segmentation covered in the Drug Treatment for Respiratory Disease Market report?

Ans: The Applications covered in the Drug Treatment for Respiratory Disease Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Drug Treatment for Respiratory Disease Market report?

Ans: The Types covered in the Drug Treatment for Respiratory Disease Market report are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Other Diseases

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Asthma

1.2.3 Chronic Obstructive Pulmonary Disease (COPD)

1.2.4 Lung Cancer

1.2.5 Other Diseases

1.3 Market by Application

1.3.1 Global Drug Treatment for Respiratory Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Treatment for Respiratory Disease Market Perspective (2019-2030)

2.2 Global Drug Treatment for Respiratory Disease Growth Trends by Region

2.2.1 Global Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drug Treatment for Respiratory Disease Historic Market Size by Region (2019-2024)

2.2.3 Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030)

2.3 Drug Treatment for Respiratory Disease Market Dynamics

2.3.1 Drug Treatment for Respiratory Disease Industry Trends

2.3.2 Drug Treatment for Respiratory Disease Market Drivers

2.3.3 Drug Treatment for Respiratory Disease Market Challenges

2.3.4 Drug Treatment for Respiratory Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Treatment for Respiratory Disease Players by Revenue

3.1.1 Global Top Drug Treatment for Respiratory Disease Players by Revenue (2019-2024)

3.1.2 Global Drug Treatment for Respiratory Disease Revenue Market Share by Players (2019-2024)

3.2 Global Drug Treatment for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Treatment for Respiratory Disease Revenue

3.4 Global Drug Treatment for Respiratory Disease Market Concentration Ratio

3.4.1 Global Drug Treatment for Respiratory Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Treatment for Respiratory Disease Revenue in 2023

3.5 Global Key Players of Drug Treatment for Respiratory Disease Head office and Area Served

3.6 Global Key Players of Drug Treatment for Respiratory Disease, Product and Application

3.7 Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Treatment for Respiratory Disease Breakdown Data by Type

4.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Type (2019-2024)

4.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030)

5 Drug Treatment for Respiratory Disease Breakdown Data by Application

5.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Application (2019-2024)

5.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drug Treatment for Respiratory Disease Market Size (2019-2030)

6.2 North America Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)

6.4 North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Treatment for Respiratory Disease Market Size (2019-2030)

7.2 Europe Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)

7.4 Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Treatment for Respiratory Disease Market Size (2019-2030)

8.2 Asia-Pacific Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Treatment for Respiratory Disease Market Size (2019-2030)

9.2 Latin America Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)

9.4 Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Treatment for Respiratory Disease Market Size (2019-2030)

10.2 Middle East & Africa Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Drug Treatment for Respiratory Disease Introduction

11.1.4 GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.1.5 GSK Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Drug Treatment for Respiratory Disease Introduction

11.2.4 AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.2.5 AstraZeneca Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Drug Treatment for Respiratory Disease Introduction

11.3.4 Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Drug Treatment for Respiratory Disease Introduction

11.4.4 Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Mylan

11.5.1 Mylan Company Details

11.5.2 Mylan Business Overview

11.5.3 Mylan Drug Treatment for Respiratory Disease Introduction

11.5.4 Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.5.5 Mylan Recent Development

11.6 Vertex Pharmaceuticals

11.6.1 Vertex Pharmaceuticals Company Details

11.6.2 Vertex Pharmaceuticals Business Overview

11.6.3 Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Introduction

11.6.4 Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.6.5 Vertex Pharmaceuticals Recent Development

11.7 F. Hoffman La Roche

11.7.1 F. Hoffman La Roche Company Details

11.7.2 F. Hoffman La Roche Business Overview

11.7.3 F. Hoffman La Roche Drug Treatment for Respiratory Disease Introduction

11.7.4 F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.7.5 F. Hoffman La Roche Recent Development

11.8 Teva Pharmaceuticals

11.8.1 Teva Pharmaceuticals Company Details

11.8.2 Teva Pharmaceuticals Business Overview

11.8.3 Teva Pharmaceuticals Drug Treatment for Respiratory Disease Introduction

11.8.4 Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.8.5 Teva Pharmaceuticals Recent Development

11.9 Cipla

11.9.1 Cipla Company Details

11.9.2 Cipla Business Overview

11.9.3 Cipla Drug Treatment for Respiratory Disease Introduction

11.9.4 Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.9.5 Cipla Recent Development

11.10 Fibrogen

11.10.1 Fibrogen Company Details

11.10.2 Fibrogen Business Overview

11.10.3 Fibrogen Drug Treatment for Respiratory Disease Introduction

11.10.4 Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.10.5 Fibrogen Recent Development

11.11 Liminal Biosciences

11.11.1 Liminal Biosciences Company Details

11.11.2 Liminal Biosciences Business Overview

11.11.3 Liminal Biosciences Drug Treatment for Respiratory Disease Introduction

11.11.4 Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.11.5 Liminal Biosciences Recent Development

11.12 PharmAkea Therapeutics

11.12.1 PharmAkea Therapeutics Company Details

11.12.2 PharmAkea Therapeutics Business Overview

11.12.3 PharmAkea Therapeutics Drug Treatment for Respiratory Disease Introduction

11.12.4 PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.12.5 PharmAkea Therapeutics Recent Development

11.13 IQVIA

11.13.1 IQVIA Company Details

11.13.2 IQVIA Business Overview

11.13.3 IQVIA Drug Treatment for Respiratory Disease Introduction

11.13.4 IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)

11.13.5 IQVIA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GSK

Astrazeneca plc

Boehringer Ingelheim

Novartis

Mylan NV

Vertex Pharmaceuticals

F. Hoffman-La Roche

Teva Pharmaceuticals

Cipla Ltd

FibroGen Inc

Liminal Biosciences

PharmAkea Therapeutics

IQVIA

List of Tables

Table 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Asthma

Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Other Diseases

Table 6. Global Drug Treatment for Respiratory Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drug Treatment for Respiratory Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Drug Treatment for Respiratory Disease Market Share by Region (2019-2024)

Table 10. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Drug Treatment for Respiratory Disease Market Share by Region (2025-2030)

Table 12. Drug Treatment for Respiratory Disease Market Trends

Table 13. Drug Treatment for Respiratory Disease Market Drivers

Table 14. Drug Treatment for Respiratory Disease Market Challenges

Table 15. Drug Treatment for Respiratory Disease Market Restraints

Table 16. Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Drug Treatment for Respiratory Disease Market Share by Players (2019-2024)

Table 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)

Table 19. Ranking of Global Top Drug Treatment for Respiratory Disease Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Drug Treatment for Respiratory Disease Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Drug Treatment for Respiratory Disease, Headquarters and Area Served

Table 22. Global Key Players of Drug Treatment for Respiratory Disease, Product and Application

Table 23. Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2019-2024)

Table 27. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2025-2030)

Table 29. Global Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2019-2024)

Table 31. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2025-2030)

Table 33. North America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)

Table 48. GSK Company Details

Table 49. GSK Business Overview

Table 50. GSK Drug Treatment for Respiratory Disease Product

Table 51. GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 52. GSK Recent Development

Table 53. AstraZeneca Company Details

Table 54. AstraZeneca Business Overview

Table 55. AstraZeneca Drug Treatment for Respiratory Disease Product

Table 56. AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 57. AstraZeneca Recent Development

Table 58. Boehringer Ingelheim Company Details

Table 59. Boehringer Ingelheim Business Overview

Table 60. Boehringer Ingelheim Drug Treatment for Respiratory Disease Product

Table 61. Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 62. Boehringer Ingelheim Recent Development

Table 63. Novartis Company Details

Table 64. Novartis Business Overview

Table 65. Novartis Drug Treatment for Respiratory Disease Product

Table 66. Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 67. Novartis Recent Development

Table 68. Mylan Company Details

Table 69. Mylan Business Overview

Table 70. Mylan Drug Treatment for Respiratory Disease Product

Table 71. Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 72. Mylan Recent Development

Table 73. Vertex Pharmaceuticals Company Details

Table 74. Vertex Pharmaceuticals Business Overview

Table 75. Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Product

Table 76. Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 77. Vertex Pharmaceuticals Recent Development

Table 78. F. Hoffman La Roche Company Details

Table 79. F. Hoffman La Roche Business Overview

Table 80. F. Hoffman La Roche Drug Treatment for Respiratory Disease Product

Table 81. F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 82. F. Hoffman La Roche Recent Development

Table 83. Teva Pharmaceuticals Company Details

Table 84. Teva Pharmaceuticals Business Overview

Table 85. Teva Pharmaceuticals Drug Treatment for Respiratory Disease Product

Table 86. Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 87. Teva Pharmaceuticals Recent Development

Table 88. Cipla Company Details

Table 89. Cipla Business Overview

Table 90. Cipla Drug Treatment for Respiratory Disease Product

Table 91. Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 92. Cipla Recent Development

Table 93. Fibrogen Company Details

Table 94. Fibrogen Business Overview

Table 95. Fibrogen Drug Treatment for Respiratory Disease Product

Table 96. Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 97. Fibrogen Recent Development

Table 98. Liminal Biosciences Company Details

Table 99. Liminal Biosciences Business Overview

Table 100. Liminal Biosciences Drug Treatment for Respiratory Disease Product

Table 101. Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 102. Liminal Biosciences Recent Development

Table 103. PharmAkea Therapeutics Company Details

Table 104. PharmAkea Therapeutics Business Overview

Table 105. PharmAkea Therapeutics Drug Treatment for Respiratory Disease Product

Table 106. PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 107. PharmAkea Therapeutics Recent Development

Table 108. IQVIA Company Details

Table 109. IQVIA Business Overview

Table 110. IQVIA Drug Treatment for Respiratory Disease Product

Table 111. IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)

Table 112. IQVIA Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Drug Treatment for Respiratory Disease Picture

Figure 2. Global Drug Treatment for Respiratory Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Drug Treatment for Respiratory Disease Market Share by Type: 2023 VS 2030

Figure 4. Asthma Features

Figure 5. Chronic Obstructive Pulmonary Disease (COPD) Features

Figure 6. Lung Cancer Features

Figure 7. Other Diseases Features

Figure 8. Global Drug Treatment for Respiratory Disease Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Drug Treatment for Respiratory Disease Market Share by Application: 2023 VS 2030

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Drug Treatment for Respiratory Disease Report Years Considered

Figure 14. Global Drug Treatment for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Drug Treatment for Respiratory Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Drug Treatment for Respiratory Disease Market Share by Region: 2023 VS 2030

Figure 17. Global Drug Treatment for Respiratory Disease Market Share by Players in 2023

Figure 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Drug Treatment for Respiratory Disease Revenue in 2023

Figure 20. North America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 22. United States Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 26. Germany Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Drug Treatment for Respiratory Disease Market Share by Region (2019-2030)

Figure 34. China Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 42. Mexico Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)

Figure 46. Turkey Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. GSK Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 50. AstraZeneca Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 51. Boehringer Ingelheim Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 53. Mylan Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 54. Vertex Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 55. F. Hoffman La Roche Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 57. Cipla Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 58. Fibrogen Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 59. Liminal Biosciences Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 60. PharmAkea Therapeutics Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 61. IQVIA Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Respiratory Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Drug Market Research Report 2024

Respiratory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Respiratory Diseases Treatment Market Insights Forecast to 2030

Global Drugs for Respiratory Diseases Market Research Report 2024

Global Expectorant Drug Market Research Report 2024

Swine Respiratory Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Inhaler Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumonia Therapeutics Market Research Report 2024

Global Asthma and COPD Devices Market Insights Forecast to 2030

Global Small Animals Respiratory Diseases Treatment Market Insights Forecast to 2030

Global Nebulizers Inhalers and Respirators for Asthma Treatment Market Research Report 2024

Respiratory Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Obstructive Pulmonary Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Breathing Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pulmonary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Asthma and COPD Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Lung Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Pulmonary Airway Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions